This systematic review evaluated microRNAs for neurological prognostication after cardiac arrest, searching four databases through July 2025. Twelve included studies examined 28 distinct microRNAs across 3021 samples, with miR-124 studied most frequently. The highest reported discrimination for miR-124 was an AUC of 0.89 (95% CI 0.80-0.97) at 48 hours after return of spontaneous circulation for poor prognosis. However, this performance was not consistently reproduced across studies and requires external validation. Variation in methods and reporting limited the evidence supporting clinical utility.
MicroRNAs, particularly miR-124, remain investigational candidates for post-arrest neuroprognostication. The reported discrimination does not establish reliable clinical utility across settings.
Study limitation: Heterogeneous methods and reporting, together with inconsistent replication, limit interpretation of the highest reported AUC.
AI-generated from the published abstract with automated source checks. For research discovery; consult the original paper before applying findings.